US Nuclear Corp

Los Angeles, CA.  February 10, 2020 - US Nuclear Corp . (OTC: UCLE) recently signed a stock purchase agreement with start-up Grapheton Inc. to acquire a 40% stake in the company.  Similar to Elon Musk’s ‘Neuralink’, Grapheton is developing and manufacturing an advanced new generation of wearable and implantable brain-machine interface devices.  Grapheton’s long-term goal is dedicated specifically to treating injuries and disease such as spinal injuries, pain reduction, Parkinson’s Disease, epilepsy, stroke, and possibly Alzheimer’s.  Grapheton already has several pivotal and patented advantages in the field, including:       .  Grapheton’s electrodes utilize a new carbon-based material that doesn’t corrode and can last as long as 40 years or more compared to less than five years from other providers, which is extremely important considering the invasive surgery requ

Chemical Drones are assuming a more noteworthy job in examination benefits nowadays. With later innovative leaps forward, for example, exceptional UAV chemical monitoring to recognize spills and auxiliary harm, drones are turning into the go to hotspot for review benefits that may incorporate risk or getting too hard to arrive at zones.  The significance of aeronautical assessments can't be thought little of, since numerous lives rely upon the accuracy of these examinations. Assessments did by physically putting the whole accentuation on the overseer and in this manner, the auditor needs to consider the peril to himself/herself, consider that every review must be exact and consider that the examination may be done as fast as could be allowed. The whole procedure by the day's end stays hazardous, requires significant investment and there is still no assuredness about the nature of the assessment. There are various fields where chemical drones are being utilized to comp